跳至主要内容
临床试验/JPRN-UMIN000021206
JPRN-UMIN000021206招募中未知

Feasibility study of perioperative chemotherapy with neoadjuvant GEM+CDDP and adjuvant S-1 for biliary tract cancer - Feasibility study of perioperative chemotherapy with neoadjuvant GEM+CDDP and adjuvant S-1 for biliary tract cancer

Keio University School of Medicine0 个研究点目标入组 30 人开始时间: 2016年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. presence of active double cancer, excluding carcinoma in situ and mucosal carcinoma 2. presence of active infection requiring systemic therapy, excluding viral hepatitis presence of other cancer except carcinoma in situ 3. accumulated pleural effusion or ascites confirmed in chest CT 4. presence of fever more than 38 degrees Celcius at registration 5. women who are pregnant or during the nursing, women who may be pregnant or are willing to get pregnant, or men who are willing to make thier partner pregnant 6. severe mental disorder 7. uncontrollable diabetes mellitus 8. uncontrollable hypertention 9. history of new-onset unstable angina within 3 weeks, progressive angina, or new-onset myocardial infarction within 6 months before registration 10. presence of severe organ dysfunction including postoperative complication (such as heart failure, renal failure, liver failure, and intestinal paralysis) 11. history of severe drug allegy 12. administered flucytosine, phenytoin, or warfarin potassium 13. uncontrollable diarrhea 14. unsuitable candidate to this study judged by a doctor

研究者

相似试验